Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Inc (NASDAQ:TLRY) shares are trading lower Monday, although there looks to be no company evident news to explain the jump in share price. Cantor Fitzgerald's Pablo Zuanic said Monday he prefers Tilray over Canopy Growth Corp (NASDAQ:CGC) for those who want exposure to the larger Canadian LPs.

Tilray's Stock Could Be In For A Ugly Move If It Can't Hold Above A Key Level

Aurora Cannabis

Canopy Growth

Marijuana earnings reports start arriving tomorrow, but Wall Street isn't optimistic.

Why Aurora Cannabis, Canopy Growth, and Tilray Stock Tumbled Today

The skeptics will fret over a vote allowing more TLRY stock shares to be issued. Yet, this move will give Tilray more financial flexibility.

Tilray Anywhere Near $12 Is an Absolute Steal

Tilray Inc.'s (NASDAQ:TLRY) (TSX:TLRY) is expanding its distribution partnership with Quebec-based ROSE LifeScience Inc through its subsidiary Tilray Canada Ltd. Under the deal, ROSE became an official partner to the recently created new entity.

Tilray Bolsters Distribution Partnership With ROSE LifeScience In Quebec

Cantor Fitzgerald analyst Pablo Zuanic shared an update on Tilray's (NASDAQ:TLRY) Aug qtr sales estimates in his Thursday note. The Analyst: Zuanic kept an “Overweight” rating on Tilray but tweaks the 12-month price target to US$18 from US$19 on lower sales estimates.

Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print

Tilray, Inc. (TLRY) closed at $12.01 in the latest trading session, marking a -0.17% move from the prior day.

Tilray, Inc. (TLRY) Dips More Than Broader Markets: What You Should Know

Tilray Inc (NASDAQ:TLRY) broke up from a descending channel Benzinga called out but then fell down to backtest the upper descending trendline of the channel and held above it. The break up from the channel was completed on high volume on the 15-minute chart, indicating the pattern was recognized but the stock lacked bullish continuation.

Tilray Stock Attempts Bullish Reversal Following New Hampshire Legalization News

Amplify Alternative Harvest ETF

The pot investment theme came out of the gate hot. But it crashed hard and hasn't found footing yet.

3 Cannabis Stocks to Buy Despite the Selloff

Clever Leaves Holdings Inc

Cannabis Stocks To Add To Your List The post Top Pot Stocks To Watch Right Now? 2 WIth Potential Upside According To Analysts appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Pot Stocks To Watch Right Now? 2 WIth Potential Upside According To Analysts

Tilray management has been struggling to meet internal targets and its plan to ramp up sales to $4 billion mark is overly optimistic at this point. TLRY stock is one to avoid for now.

Tilray Stock Investors Shouldn't Count on Help From $4 Billion Plan

Shares of cannabis giant Tilray Inc. (NASDAQ:TLRY) (TSX: TLRY) are trading down on Friday afternoon, after the company reporting that its stockholders have approved an increase in the number of authorized shares of its common stock. As such, the cannabis company said that with additional authorized shares, it can accelerate its progress toward its goal of delivering $4 billion in revenue, a goal Tilray CEO Irwin Simon told Benzinga it intended to achieve by the end of fiscal 2024.

Tilray Stockholders Approve Increase In Number Of Shares To Help Drive $4B In Revenue, Stock Trades Down

Tilray Inc. (NASDAQ:TLRY) shares were trading lower Friday after shareholders approved an increase in the number of authorized shares of its common stock. The stock looks be coming to the end of a technical pattern and soon could see a large push in movement.

Where Tilray Might Go In Coming Weeks As Cannabis Stock Nears End Of Pattern

Following their strategic merger with Aphria, TLRY is the largest commercial marijuana company in Canada.

Tilray Stands To Benefit From A Variety Of Factors

Making A Marijuana Stocks Watchlist In September? Here's 2 You Might Want To Check Out The post 2 Hot Marijuana Stocks To Watch For September 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

2 Hot Marijuana Stocks To Watch For September 2021

Alphabet

2 Market-Crushing Stocks That Analysts Think Can Still Soar Higher

Cronos Group

Which Canadian Cannabis Company Is In the Best Position to Enter the U.S. Market?

NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray”) (NASDAQ | TSX: TLRY) a leading global cannabis-lifestyle and consumer packaged goods company, announced today that Irwin D Simon, Chairman and Chief Executive Officer, Tilray, and Carl Merton, Chief Financial Officer, Tilray, will participate in the Barclays Global Consumer Staples Conference on Friday, September 10, 2021 at 10:00 a.m. Eastern Time. The live audio webcast will be accessible in the Events & Presentation

Tilray to Participate in Barclays Global Consumer Staples Conference on September 10th, 2021

Tilray continues to urge shareholders to approve Proposal 1 to lift the authorized share count to 990 million shares. The Canadian cannabis company has proposed a plan to boost FY24 (June) revenue to $4 billion while current analyst estimates are only $1.37 billion.

Tilray: 250 Million Reasons Shareholders Aren't Happy

HEXO Corp

OrganiGram Holdings Inc.

As COVID-related restrictions begin to ease across the globe, some industries are feeling the benefits more than others. When it comes to Canadian recreational cannabis sales, new Hifyre scanner data reveals a 10% improvement sequentially, noted Cantor Fitzgerald's Pablo Zuanic in his latest industry report.

Organigram On Pace To Beat Tilray And Hexo In QoQ Sales Growth As Canadian Rec. Sales Reach $275.6M

One of the largest craft brewers in terms of volume in the U.S., SweetWater Brewing Company, LLC announced Friday that it has launched a new and innovative non-dairy almond milk stout. The new brew offers an authentic stout taste balanced with delicate almond sweetness.

Tilray: From Cannabis To Non-Dairy Almond Milk Stout – Canadian Giant's SweetWater Brewing Launches New Brew

ATLANTA--(BUSINESS WIRE)--SweetWater Brewing Company, LLC ("SweetWater") has announced the launch of its new and innovative Non-Dairy Almond Milk Stout - a fresh take on classic dairy milk stouts packed with bold flavors, but with a unique twist. This deliciously smooth, dark and tasty brew still has an authentic stout taste balanced with subtle almond sweetness to create the ultimate stout-drinking experience. SweetWater's latest tasty brew is skillfully crafted for all beer drinkers and stout

SweetWater Brewing Company Launches Innovative New Plant-based, Non-Dairy Almond Milk Stout

Cannabis companies continue to consolidate and make plans for potential legalization in the U.S.

Why Tilray, Canopy Growth, and Hexo Stock Rose Today

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

Amplify US Alternative Harvest ETF

MedMen Enterprises Inc.

AdvisorShares Pure US Cannabis ETF

Global X Cannabis ETF

Trulieve Cannabis Corp.

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Vice ETF

AdvisorShares Pure Cannabis ETF 

Waiting For The Top Down In Cannabis (Podcast)

Tilray stock had enjoyed a 62% run up between mid-May and mid-June after it finalized its merger with former rival Aphria. The deal made Tilray the largest Canadian cannabis producer with annual revenues of $1 billion and a 17% share of the North American retail market for the recreational drug.

Tilray Stock Will Say in Limbo Until the U.S. Legalizes Cannabis

Could These Canadian Marijuana Stocks Deliver Gains In Q4 2021? The post Top Canadian Cannabis Stocks In September 2021 appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks In September 2021

News for Tilray Brands Stock (TLRY)